Home/Pipeline/Precision Dosing Platform

Precision Dosing Platform

Platform Development

Pre-clinicalActive

Key Facts

Indication
Platform Development
Phase
Pre-clinical
Status
Active
Company

About Hikari Medical Technologies

Hikari Medical Technologies is an early-stage medical device innovator tackling a critical problem in healthcare: imprecise drug dosing, which it cites as causing over 9,000 patient deaths and 1.3 million injuries annually at a cost of $40B+ to the system. The company is developing a first-of-its-kind, non-invasive platform for precision drug dosing designed to personalize and adapt medication delivery. As a private, pre-revenue company, Hikari is in the technology development stage, building its team and platform with an initial focus on creating a critical competitive advantage in the adaptive medicine space.

View full company profile

Other Platform Development Drugs

DrugCompanyPhase
ALTHEA Gold Libraries PlatformGlobalBioN/A
Assay AutomationPathoFinderDevelopment